Inanovate has developed a patented blood analysis system for use in research and diagnostic applications. The system, called the Bio-ID, detects and quantifies the presence of disease related biological molecules (biomarkers) from patient samples, in one low-cost accurate test. The Bio-ID lowers the cost, sample use and variability of diagnostic tests, while reducing both the duration and cost of clinical trials.